# Elrexfio

NDC: 63539-252
Generic name: elranatamab-bcmm
Labeler / Manufacturer: U.S. Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230815

FDA application: BLA761345

## Active ingredients

- ELRANATAMAB: 44 mg/1.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63539-252"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63539-252